Welcome Center  |   Log In  |   Register  |   Follow Us  Facebook  Twitter Google Plus

Latest in Allergy & Clinical Immunology

Reuters Health • The Doctor's Channel Daily Newscast

Long-term abatacept safe, usually effective for juvenile idiopathic arthritis

NEW YORK (Reuters Health) – Four out of five children with juvenile idiopathic arthritis had a good clinical response to abatacept during a long-term open-label extension trial. The safety profile was good, and the level of response often increased...

Reuters Health • The Doctor's Channel Daily Newscast

Montelukast cuts recurrent wheezing with RSV bronchiolitis

NEW YORK (Reuters Health) – Montelukast (Singulair), a leukotriene receptor antagonist, can help prevent recurrent wheezing episodes after respiratory syncytial virus (RSV) bronchiolitis, new research shows. From earlier work, the researchers knew...

Reuters Health • The Doctor's Channel Daily Newscast

Belatacept-based immunosuppression spares renal function in kidney recipients

NEW YORK (Reuters Health) – Belatacept-based immunosuppression after kidney transplantation allows for better renal function compared to cyclosporine, with similar graft and patient survival, phase III trial results suggest. In kidney allograft...